• © 2024 stocknear. All Rights Reserved.
DNA Ginkgo Biowo...

Analyst Ratings

Total Analyst

The total number of analyst who provided a rating in the past 12 months.
0

Consensus Rating

The average analyst rating for DNA is standardized to align with categories: Strong Buy, Buy, Hold, Sell, and Strong Sell.
n/a

Price Target

The average 12-month price target
$n/a

Upside

The average price target's percentage difference from the current stock price.
+0%

Ratings History

In previous years, Wall Street analysts have given Ginkgo Bioworks Inc. a total of 25 ratings.

Top Analysts

Filter for analysts rated 4+ stars focusing on their win rate and average return per rating. Analysts with 4+ stars typically exhibit both high accuracy and high return per rating.
Analyst Rating Date
Mark Massaro BTIG
(0)
Sell Downgrades
May 15, 2024
Tejas Savant Morgan Stanley
(0)
Hold Maintains
$2 $1
May 15, 2024
Matt Larew William Blair
(0)
Sell Downgrades
May 10, 2024
Steven Mah TD Cowen
(2.5)
Buy Maintains
$7 $3
Mar 1, 2024
Matthew Sykes Goldman Sachs
(3.9)
Sell Maintains
$2 $2
Jan 23, 2024

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

and even more...

Become a Pro
Ginkgo Bioworks Inc.
Current Price: $null Holding Shares: 0

Type of Trade

Add to Watchlist